Rivastigmine Tartrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers, 18 USDMF, 12 CEP/COS, 15 EU WC, 18 KDMF, 6 NDC API, 24 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

9 Suppliers

9 Suppliers

DOSSIERs // Finished Dosage Forms

120 Dossiers, 46 FDA Orange Book, 40 Europe, 29 Canada, 5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 17 Roquette, 15 Kerry, 10 Corel Pharma Chem, 10 Microlex e.U, 8 BASF, 8 Seppic, 8 Sigachi Industries, 6 Gangwal Healthcare, 6 Gangwal Chemicals, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 SPI Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 ACG Worldwide, 3 Kima Chemical, 2 DFE Pharma, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 2 Qualicaps, 2 Ingredion Pharma Solutions, 2 Prachin Chemical, 1 Nanjing Well Pharmaceutical, 1 Pharmatrans-Sanaq, 1 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Direct Compression, 15 Lubricants & Glidants, 14 Thickeners and Stabilizers, 11 Granulation, 11 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Taste Masking, 8 Co-Processed Excipients, 6 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Topical, 3 Emulsifying Agents, 2 Coloring Agents, 2 Solubilizers, 2 Rheology Modifiers, 1 Parenteral

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS

11 Health Canada Patents

11 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

7 News

7 News

Approved Marketing Authorisations (MA) containing Rivastigmine Tartrate in Europe. Original Data : EMA Website

Rivastigmine Tartrate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers

18 USDMF

12 CEP/COS

15 EU WC

18 KDMF

6 NDC API

24 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

9 Suppliers

DOSSIERs // Finished Dosage Forms

120 Dossiers

46 FDA Orange Book

40 Europe

29 Canada

5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

17 Roquette

15 Kerry

10 Corel Pharma Chem

10 Microlex e.U

8 BASF

8 Seppic

8 Sigachi Industries

6 Gangwal Healthcare

6 Gangwal Chemicals

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 SPI Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 ACG Worldwide

3 Kima Chemical

2 DFE Pharma

2 The Dow Chemical Company

2 Vasa Pharmachem

2 Qualicaps

2 Ingredion Pharma Solutions

2 Prachin Chemical

1 Nanjing Well Pharmaceutical

1 Pharmatrans-Sanaq

1 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives

35 Fillers, Diluents & Binders

21 Controlled & Modified Release

18 Direct Compression

15 Lubricants & Glidants

14 Thickeners and Stabilizers

11 Granulation

11 Film Formers & Plasticizers

10 Disintegrants & Superdisintegrants

9 Empty Capsules

9 Taste Masking

8 Co-Processed Excipients

6 Chewable & Orodispersible Aids

4 Vegetarian Capsules

4 API Stability Enhancers

4 Topical

3 Emulsifying Agents

2 Coloring Agents

2 Solubilizers

2 Rheology Modifiers

CAPSULE;ORAL - EQ 1.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 4.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons